These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3446773)

  • 21. A limited sampling method for the estimation of AUC and Cmax of carbamazepine and carbamazepine epoxide following a single and multiple dose of a sustained-release product.
    Mahmood I; Chamberlin N
    Br J Clin Pharmacol; 1998 Mar; 45(3):241-6. PubMed ID: 9517367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of diosmin on the metabolism and disposition of carbamazepine in healthy subjects.
    Bedada SK; Boga PK
    Xenobiotica; 2017 Oct; 47(10):879-884. PubMed ID: 27690733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of denzimol on carbamazepine and carbamazepine-10,11-epoxide concentrations in serum, liver, spleen and different brain regions of the rat: an inhibitory metabolic interaction.
    Patsalos PN; Alavijeh MS; Brownhill W; Lascelles PT
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jan; 337(1):111-4. PubMed ID: 3368010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbamazepine metabolism in man. Induction and pharmacogenetic aspects.
    Eichelbaum M; Tomson T; Tybring G; Bertilsson L
    Clin Pharmacokinet; 1985; 10(1):80-90. PubMed ID: 3971637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo determinations of carbamazepine and carbamazepine-10, 11-epoxide binding parameters to serum proteins in monotherapy patients.
    Kodama Y; Kuranari M; Kodama H; Fujii I; Takeyama M
    J Clin Pharmacol; 1993 Sep; 33(9):851-5. PubMed ID: 8227483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbamazepine and carbamazepine-10,11-epoxide clearance measurements during continuous venovenous hemofiltration in a massive overdose.
    Smollin CG; Petrie MS; Kearney T
    Clin Toxicol (Phila); 2016 Jun; 54(5):424-7. PubMed ID: 26942940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of phenobarbital on the pharmacokinetics of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
    Spina E; Martines C; Fazio A; Trio R; Pisani F; Tomson T
    Ther Drug Monit; 1991 Mar; 13(2):109-12. PubMed ID: 2053116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbamazepine 10,11-epoxide in children.
    Rylance GW; Edwards C; Gard PR
    Br J Clin Pharmacol; 1984 Dec; 18(6):935-9. PubMed ID: 6529533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoinduction and steady-state pharmacokinetics of carbamazepine and its major metabolites.
    Kudriakova TB; Sirota LA; Rozova GI; Gorkov VA
    Br J Clin Pharmacol; 1992 Jun; 33(6):611-5. PubMed ID: 1389933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A partial area difference analysis for estimating elimination rate constants and distribution volumes of metabolites.
    Riad LE; Sawchuk RJ
    J Pharm Sci; 1998 Jun; 87(6):769-73. PubMed ID: 9607957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on interactions between traditional herbal and Western medicines. IV: lack of pharmacokinetic interactions between Saiko-ka-ryukotsu-borei-to and carbamazepine in rats.
    Ohnishi N; Nakasako S; Okada K; Umehara S; Takara K; Nagasawa K; Yoshioka M; Kuroda K; Yokoyama T
    Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):129-35. PubMed ID: 11554427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose.
    Vree TB; Janssen TJ; Hekster YA; Termond EF; van de Dries AC; Wijnands WJ
    Ther Drug Monit; 1986; 8(3):297-304. PubMed ID: 3750374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbamazepine dose requirements during stiripentol therapy: influence of cytochrome P-450 inhibition by stiripentol.
    Kerr BM; Martinez-Lage JM; Viteri C; Tor J; Eddy AC; Levy RH
    Epilepsia; 1991; 32(2):267-74. PubMed ID: 2004631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing serum levels of carbamazepine and carbamazepine-10,11-epoxide in children.
    Altafullah I; Talwar D; Loewenson R; Olson K; Lockman LA
    Epilepsy Res; 1989; 4(1):72-80. PubMed ID: 2753022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concentrations of carbamazepine and carbamazepine-10, 11-epoxide in serum, brain tumors and paratumorous cortex: a prospective study of 37 neurosurgically treated epileptic patients.
    Schnabel R; Rambeck B; May TW; Jürgens U; Lahl R
    Eur Neurol; 1994; 34(4):213-20. PubMed ID: 8082680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication.
    Svinarov DA; Pippenger CE
    Ther Drug Monit; 1996 Dec; 18(6):660-5. PubMed ID: 8946662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants.
    Brodie MJ; Forrest G; Rapeport WG
    Br J Clin Pharmacol; 1983 Dec; 16(6):747-9. PubMed ID: 6661364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased bioavailability of carbamazepine suppository after its intrarectal and intracolostomal administration to rectal-resected or colostoma-constructed rabbits.
    Nagasawa K; Nakanishi H; Yamamoto R; Kintsuji S; Fujimoto S
    Int J Pharm; 2002 Jul; 241(2):375-84. PubMed ID: 12100865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
    Carlsson KC; Hoem NO; Glauser T; Vinks AA
    Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of lamotrigine on the pharmacokinetics of carbamazepine and its active metabolite in dogs.
    Matar KM; Nicholls PJ; Bawazir SA; Al-Khamis KI; Al-Hassan MI
    Eur J Drug Metab Pharmacokinet; 2001; 26(3):149-53. PubMed ID: 11695714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.